课题基金 / 基金详情

Measuring the Impact of the Value Flower and Unobserved Heterogeneity on the Cost Effectiveness and Use of Novel Treatments for Alzheimer's Disease and Related Dementias

Measuring the Impact of the Value Flower and Unobserved Heterogeneity on the Cost Effectiveness and Use of Novel Treatments for Alzheimer's Disease and Related Dementias
衡量价值花和未观察到的异质性对阿尔茨海默病和相关痴呆症新疗法的成本效益和使用的影响
批准号:
10658457
负责人:
ADAM J ATHERLY
金额:
$32.12万
依托单位国家:
美国
项目类别:
财政年份:
2023
资助国家:
美国
项目状态:
未结题
起止时间:
2023-06-15 至 2025-05-31
关键词:
AccelerationAducanumabAdverse effectsAfrican AmericanAge of OnsetAlzheimer&aposs DiseaseAlzheimer&aposs disease related dementiaAlzheimer&aposs disease riskAlzheimer&aposs disease therapeuticAmyloidAmyloid beta-ProteinBlack AmericanBlack PopulationsCalibrationCaregiver BurdenCaregiversCaringClinical TrialsCommunitiesContinuity of Patient CareCost Effectiveness AnalysisCosts and BenefitsDataDiagnosisDisparityEarly treatmentEconometric ModelsEconomicsElementsEquationFamilyFamily memberFinancial HardshipFlowersFocus GroupsGrantHeterogeneityHispanic AmericansInequalityLife ExpectancyLiteratureLogit ModelsMeasuresMedicareMethodologyMethodsMinority GroupsModelingMonoclonal AntibodiesMotivationOutcomePatientsPharmaceutical PreparationsPharmacological TreatmentPhasePoliciesPopulationPrevalenceProbabilityQuality-Adjusted Life YearsRaceReduce health disparitiesResearchResearch MethodologyResourcesRiskSeverity of illnessStructureTherapeuticUnited StatesUnited States Centers for Medicare and Medicaid ServicesUnited States Food and Drug AdministrationUpdatecare giving burdencaucasian Americanclinical efficacyclinical trial enrollmentcommunity based participatory researchcostcost effectivenesscost estimatedata modelingdiscrete dataeconomic valueethnic differenceethnic minorityethnoracialethnoracial minorityexperimental studyfamily burdenhealth equityhealthy agingimprovedmarkov modelmodels and simulationnovelnovel therapeuticspreferenceracial differenceracial minorityracial populationtreatment and outcometreatment disparitytrendunderserved areauptake

项目摘要

项目成果

ADAM J ATHERLY的其他基金

相似基金

相关文献

中文摘要
翻译
项目总结
英文摘要
Project Summary This purpose of this project is to use a combination of Markov models, stated preference data and econometric models of treatment take-up to calculate the costs, benefits, societal value and health equity impacts of novel treatments or Alzheimer disease and Alzheimer's disease-related dementias (AD/ADRD). In this project, we will study the health equity implications of the cost effectiveness models new novel treatments for AD/ADRD using a combination of Markov models, data from the literature and clinical trials, community based participatory research (CBPR) with focus groups and experimental preference data. First, we will update our existing cost effectiveness Markov model (developed for aducanumab and donanemab for early Alzheimer disease in the United States) in incorporate race specific inputs into the start values and transition probabilities. Next, we will engage in CBPR by conducting focus groups on AD/ADRD with at-risk African-American/Black individuals in a poor, underserved area (Richmond, VA). In this, we will leverage pre-existing relationships to engage with community partners working on healthy aging. We will also conduct focus groups with caregivers to understand the effect of caregiver burden. We will use the results of the models to measure the economic value of reducing AD/ADRD in different populations using experimental stated preference data from Discrete Choice Experiments. Finally, we will estimate models of treatment take-up using a combination of latent choice and mixed logit models to control for both observed and unobserved preference heterogeneity both between different racial groups and within racial groups. We will calibrate our models using nationally representative Medicare data to simulate take-up rates, and subsequent costs and benefits to new treatments plus the impact of health equity. Finally, we will develop simulation models based on the take-up rates to identify policy changes that could be used to ensure that new treatment improve health equity.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
The effects of medicare advantage payment reductions on low income elderly medicare beneficiaries
  • 批准号:
    9134671
  • 项目类别:
  • 资助金额:
    $15.1万
  • 财政年份:
    2015
  • 负责人:
    ADAM J ATHERLY
  • 依托单位:
The effects of medicare advantage payment reductions on low income elderly medicare beneficiaries
The effects of medicare advantage payment reductions on low income elderly medicare beneficiaries
  • 批准号:
    9007185
  • 项目类别:
  • 资助金额:
    $23.31万
  • 财政年份:
    2015
  • 负责人:
    ADAM J ATHERLY
  • 依托单位:
Implications of Switching Costs for Medicare Premium Support
  • 批准号:
    8738580
  • 项目类别:
  • 资助金额:
    $7.6万
  • 财政年份:
    2013
  • 负责人:
    ADAM J ATHERLY
  • 依托单位:
海外基金